医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Scanditronic becomes Ascom

2014年12月16日 AM10:00
このエントリーをはてなブックマークに追加


 

KUALA LUMPUR, Malaysia & GOTHENBURG, Sweden

Ascom, a global provider of mission-critical communications systems, recently acquired Scanditronic, a distributor of Ascom’s products in Malaysia and the South East Asia region.

As of November 1st Scanditronic has changed its legal entity name to Ascom (Malaysia) Sdn. Bhd. and will be running under the Ascom Wireless Solutions division which is headquartered in Gothenburg, Sweden.

Ascom (Malaysia) will lead all of the Ascom Wireless Solutions operations in the South East Asian region, delivering mobility, nurse call and middleware solutions for the healthcare, retail, hospitality and shipping segments. The acquisition will further strengthen the support to existing customers, and enhances Ascom’s presence in South East Asia.

For more information visit www.ascom.com/ws

ABOUT ASCOM WIRELESS SOLUTIONS

Ascom Wireless Solutions (www.ascom.com/ws) is a leading provider of on-site wireless communications for key segments such as hospitals, elderly care, independent living, manufacturing industries, secure establishments, retail and hotels. More than 75,000 systems are installed at major companies all over the world. The company offers a broad range of voice and professional messaging solutions, creating value for customers by supporting and optimizing their Mission-Critical processes. The solutions are based on VoWiFi, IP-DECT, nurse call and paging technologies, smartly integrated into existing enterprise systems. The company has subsidiaries in 13 countries and 1,200 employees worldwide. Founded in 1955 and based in Göteborg, Sweden, Ascom Wireless Solutions is part of the Ascom Group, listed on the Swiss Stock Exchange.

CONTACT

Ascom Malaysia
Hans Tysk, Managing Director,
Tel: +60 342 52
47 49
Email: Hans.Tysk@ascom-ws.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表